SABS
SAB Biotherapeutics, Inc.
$3.77
-0.13 (-3.33%)
At close · Jul 8
Market Cap
$302.80M
Shares
76,464,094
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding SABS
12 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,123,393 | $8,132,595 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 304,894 | $1,167,744 | 0.00% | Long | 2026-03-31 | |
| Simplify Propel Opportunities ETF | — | 187,230 | $717,091 | 1.03% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 47,303 | $193,942 | 0.00% | Long | 2026-02-28 | |
| Blackstone Alternative Multi-Strategy Fund | — | 38,992 | $149,339 | 0.00% | Long | 2026-03-31 | |
| VANGUARD BALANCED INDEX FUND | — | 37,595 | $143,989 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 32,163 | $131,868 | 0.00% | Long | 2026-02-28 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 27,855 | $106,685 | 0.00% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 25,572 | $104,845 | 0.00% | Long | 2026-02-28 | |
| Fidelity Total Market Index Fund | — | 12,827 | $52,591 | 0.00% | Long | 2026-02-28 | |
| Fidelity Series Total Market Index Fund | — | 10,619 | $43,538 | 0.00% | Long | 2026-02-28 | |
| Victory Extended Market Index Fund | — | 4,211 | $15,749 | 0.00% | Long | 2026-04-30 |
Showing 1–12 of 12 positions